Abbott Gets Green Light to Buy Rest of Ibis

(AP) — Abbott Laboratories received antitrust regulatory approval for its $175 million buyout of the remaining stake in Ibis Biosciences Inc. from Isis Pharmaceuticals Inc., the companies said Tuesday. U.S. regulators cleared the deal under the Hart-Scott-Rodino Antitrust Improvements Act of ...

Copyright CRAIN - Crain's
Contact Us